Literature DB >> 5073956

The medical problems of mass participation in athletic competition. The "City-to-Surf" race.

J Sutton, M J Coleman, A P Millar, L Lazarus, P Russo.   

Abstract

Mesh:

Substances:

Year:  1972        PMID: 5073956

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


× No keyword cloud information.
  15 in total

1.  Plasma Hsp72 is higher in runners with more serious symptoms of exertional heat illness.

Authors:  P A Ruell; M W Thompson; K M Hoffman; J R Brotherhood; D A B Richards
Journal:  Eur J Appl Physiol       Date:  2006-06-24       Impact factor: 3.078

2.  Medical hazards of a four-km fun run.

Authors:  H Bethell; D Jewell; P Burke
Journal:  Br J Sports Med       Date:  1991-12       Impact factor: 13.800

3.  Primary prevention of heat stroke in Canadian long-distance runs.

Authors:  R L Hughson
Journal:  Can Med Assoc J       Date:  1980-05-24       Impact factor: 8.262

Review 4.  Is it time to retire the 'central governor'?

Authors:  Roy J Shephard
Journal:  Sports Med       Date:  2009       Impact factor: 11.136

5.  Climate and physiological heat strain during exercise.

Authors:  C R de Freitas; M G Ryken
Journal:  Int J Biometeorol       Date:  1989-10       Impact factor: 3.787

6.  The elite marathon runner: problems during and after competition.

Authors:  P Hölmich; E Darre; F Jahnsen; T Hartvig-Jensen
Journal:  Br J Sports Med       Date:  1988-03       Impact factor: 13.800

7.  Heat stroke or hypothermia?

Authors:  J R Sutton
Journal:  Br Med J       Date:  1979-05-19

8.  Androgen responses during physical exercise.

Authors:  J R Sutton; M J Coleman; J Casey; L Lazarus
Journal:  Br Med J       Date:  1973-03-03

9.  Marathon running and adverse weather conditions: a miscellany.

Authors:  A M Porter
Journal:  Br J Sports Med       Date:  1984-12       Impact factor: 13.800

10.  Lactate and glucose exchange across the forearm, legs, and splanchnic bed during and after prolonged leg exercise.

Authors:  G Ahlborg; P Felig
Journal:  J Clin Invest       Date:  1982-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.